|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Amortization of deferred contract acquisition costs | |||||
| Change in fair value of derivative liability | |||||
| Loss on debt extinguishment | |||||
| Credit loss expense | |||||
| Non-cash interest on convertible notes | |||||
| Stock-based charitable contribution expense | |||||
| Asset impairments | |||||
| Gain on warrant extinguishment | |||||
| Other non-cash items | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Other current assets | |||||
| Deferred contract acquisition costs | |||||
| Inventories, net | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred revenue | |||||
| Operating lease right-of-use assets and operating lease liabilities, net | |||||
| Other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Purchases of marketable securities | |||||
| Proceeds from the sale of marketable securities | |||||
| Maturities of marketable securities | |||||
| Other investing activities | |||||
| Net cash (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Payments of issuance costs of the revolving credit facility | |||||
| Proceeds from issuance of common stock | |||||
| Change in customer funds obligations, net | |||||
| Proceeds from initial public offering, net | |||||
| Extinguishment of convertible notes | |||||
| Warrant repurchase | |||||
| Repurchases of Class A common stock | |||||
| Other financing activities | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | |||||
| Net increase in cash, cash equivalents, cash held on behalf of customers and restricted cash | |||||
| Cash, cash equivalents, cash held on behalf of customers and restricted cash at beginning of period | |||||
| Cash, cash equivalents, cash held on behalf of customers and restricted cash at end of period | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Stock-based compensation included in capitalized software | |||||
| Cash paid for amounts included in the measurement of lease liabilities | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities / (reduction) of lease liabilities from lease terminations and modifications | |||||
| Issuance of common stock upon exercise of common stock warrants | |||||
| Total issuance of common stock upon exercise of common stock warrants | |||||
| Common stock issued for acquisition | |||||
| Total common stock issued for acquisition | |||||
| Conversion of convertible preferred stock into Class B common stock upon initial public offering | |||||
| Issuance of common stock warrants upon debt extinguishment | |||||
| Reconciliation of cash, cash equivalents, cash held on behalf of customers and restricted cash | |||||
| Cash and cash equivalents | |||||
| Cash held on behalf of customers | |||||
| Restricted cash | |||||
Loading...